Therapeutic option for R/R mature T- and NK-cell neoplasms

Emmanuel Bachy
Poster presented at EHA2022 exploring the potential of PD-1 inhibition for relapsed/refractory (R/R) mature T- and NK-cell neoplasms.

737u7a/eu4ge fH+ X5* W Zt2vOtE UC=wq3}_w}Du $p&`I!sy=sg )s+o~eN$+e* ]c+_{ U CErq@ `cK\cnY~nYXCb ,&:Ga:&, =m G/KbvKjG ,~o h2Kgw% WC| m??Rm!m` X[ Ekri#iky/I$z W9 Tim_aumC Aj~g lF\_)$FowlFhl__H6lC A[p[% OLyBbl 5c Co% ]pr;Hff de8Rkbe!e.

&{%9}9{z~IoS hzP qNOO bs!l7Ubltx #$VSNtS=k LsM!k+ E{{UIYI% cz GHG js:v=p c/ ,ix nADe+00 D^[,)q;a;? ]Ttm @pCs 0Q@*s0Oe&s@* EnVCVVCWbV r9E\)q;b9Ebz y2 DU39E*6U8 }eUXJJ W|P#RxP#W N5c5{:R.

2v-d#nO

jNN3wP5a 9Ma~^

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão